Updated Jul 16, 2026
Sauer Noel has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $6.
Noel Sauer is a corporate executive currently serving as the Senior Vice President of Research at Cibus, Inc., a company focused on agricultural biotechnology. His role involves overseeing research initiatives aimed at developing innovative solutions in crop improvement and sustainability.
| Role | Sr VP, Research |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-28 | CBUS | Cibus, Inc. | A — Grant or award | 38.0K | $0.00 | |
| 2026-04-01 | CBUS | Cibus, Inc. | F — Tax withholding / forfeiture | 1.8K | $1.84 | $3K |
| 2026-03-18 | CBUS | Cibus, Inc. | F — Tax withholding / forfeiture | 1.8K | $1.32 | $2K |
| 2026-03-18 | CBUS | Cibus, Inc. | S — Open-market sale | 4 | $1.49 | $6 |
Noel Sauer is a corporate executive currently serving as the Senior Vice President of Research at Cibus, Inc., a company focused on agricultural biotechnology. His role involves overseeing research initiatives aimed at developing innovative solutions in crop improvement and sustainability.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($6) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sauer Noel profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.